Anti-SC6A6/ SLC6A6/ TAUT monoclonal antibody

Anti-SC6A6/ SLC6A6/ TAUT antibody for FACS & in-vivo assay

Target products collectionGo to SLC6A6/SLC6A6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1659-Ab-1/ GM-Tg-hg-MP1659-Ab-2Anti-Human SLC6A6 monoclonal antibodyHuman
GM-Tg-rg-MP1659-Ab-1/ GM-Tg-rg-MP1659-Ab-2Anti-Rat SLC6A6 monoclonal antibodyRat
GM-Tg-mg-MP1659-Ab-1/ GM-Tg-mg-MP1659-Ab-2Anti-Mouse SLC6A6 monoclonal antibodyMouse
GM-Tg-cynog-MP1659-Ab-1/ GM-Tg-cynog-MP1659-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC6A6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1659-Ab-1/ GM-Tg-felg-MP1659-Ab-2Anti-Feline SLC6A6 monoclonal antibodyFeline
GM-Tg-cang-MP1659-Ab-1/ GM-Tg-cang-MP1659-Ab-2Anti-Canine SLC6A6 monoclonal antibodyCanine
GM-Tg-bovg-MP1659-Ab-1/ GM-Tg-bovg-MP1659-Ab-2Anti-Bovine SLC6A6 monoclonal antibodyBovine
GM-Tg-equg-MP1659-Ab-1/ GM-Tg-equg-MP1659-Ab-2Anti-Equine SLC6A6 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1659-Ab-1/ GM-Tg-hg-MP1659-Ab-2; GM-Tg-rg-MP1659-Ab-1/ GM-Tg-rg-MP1659-Ab-2;
GM-Tg-mg-MP1659-Ab-1/ GM-Tg-mg-MP1659-Ab-2; GM-Tg-cynog-MP1659-Ab-1/ GM-Tg-cynog-MP1659-Ab-2;
GM-Tg-felg-MP1659-Ab-1/ GM-Tg-felg-MP1659-Ab-2; GM-Tg-cang-MP1659-Ab-1/ GM-Tg-cang-MP1659-Ab-2;
GM-Tg-bovg-MP1659-Ab-1/ GM-Tg-bovg-MP1659-Ab-2; GM-Tg-equg-MP1659-Ab-1/ GM-Tg-equg-MP1659-Ab-2
Products NameAnti-SLC6A6 monoclonal antibody
Formatmab
Target NameSLC6A6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC6A6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SC6A6/ SLC6A6/ TAUT VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1659
    Target NameSLC6A6
    Gene ID6533,21366,29464,701172,404000,101101373,282366,100055795
    Gene Symbol and SynonymsHTRDC,SLC6A6,TAUT
    Uniprot AccessionP31641,P31643,Q00589,Q9MZ34
    Uniprot Entry NameSC6A6_HUMAN,SC6A6_RAT,SC6A6_CANLF,SC6A6_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000131389
    Target ClassificationN/A

    The target: SLC6A6, gene name: SLC6A6, also named as TAUT. This gene encodes a multi-pass membrane protein that is a member of a family of sodium and chloride-ion dependent transporters. The encoded protein transports taurine and beta-alanine. There is a pseudogene for this gene on chromosome 21. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.